<![CDATA[Is Vitamin C an Epigenetic Interception Strategy in Pre-Leukemic Disease?]]>

Summary

Peter A. Jones, PhD, DSc (hon), discusses vitamin C as a potent epigenetic drug and its potential role as an interception strategy in pre-leukemic disease. The article provides expert commentary and no trial results, regulatory actions, or company news.